Status:
RECRUITING
Genetic Risks for Childhood Cancer Complications in Switzerland
Lead Sponsor:
University Hospital, Geneva
Conditions:
Childhood Cancer
Genetic Predisposition
Eligibility:
All Genders
Up to 21 years
Brief Summary
The objectives of the GECCOS project are to identify genetic variants associated with complications of childhood cancer using genotype-phenotype association studies. Germline genetic samples and data ...
Detailed Description
Background and rationale : Around 300 children and adolescents are diagnosed with cancer each year in Switzerland. A wide range of acute and chronic complications have been linked to cancer and its t...
Eligibility Criteria
Inclusion
- Registered in the Swiss Childhood Cancer Registry (SCCR) since 1976; AND
- consented to the BaHOP (host biobank for the BISKIDS Biobanking project); AND
- diagnosed with cancer according to the International Classification of Childhood Cancer, version 3, ICCC-3, or Langerhans cell histiocytosis (LCH) before age 21 years.
Exclusion
- Lacking written consent signed by participant and/ or their legal representative to participate in the BaHOP (where applicable); OR
- died after study participation and declined use of their samples and data after their death in the original consent for BaHOP (as indicated on the BaHOP consent).
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2037
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT04702321
Start Date
December 1 2020
End Date
December 31 2037
Last Update
January 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Geneva
Geneva, Switzerland, 1211